Drugs / FluMist/B/Yamagata
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01091246 | Mar → Jul 2010 | — | MedImmune LLC | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluMist/B/Yamagata | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01091246 ↗ |
| Modality | Vaccine | “trivalent live attenuated influenza vaccine” NCT01091246 ↗ |
| Route | Intranasal | “intranasal dose” NCT01091246 ↗ |